Showing results (271-280 of 538) with videos related to
Sort By:
Pageof 54
Annual Review of Biochemistry|June 29, 2000
Functions of cell surface heparan sulfate proteoglycansM Bernfield, M Götte, P W Park, et al.Psychopharmacology|December 14, 2011
Quinpirole elicits differential in vivo changes in the pre- and postsynaptic distributions of dopamine D₂ receptors in mouse striatum: relation to cannabinoid-1 (CB₁) receptor targetingDiane A Lane, June Chan, Megan L Fitzgerald, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 9, 2018
A simple matrix to predict treatment success and long-term survival among patients undergoing pancreatectomyTimothy L Fitzgerald, Lucas Hunter, Catalina Mosquera, et al.Journal of Surgical Oncology|April 23, 2002
Ex vivo sentinel lymph node biopsy in colorectal cancer: a feasibility studyT L Fitzgerald, M A Khalifa, M Al Zahrani, et al.The American Surgeon|May 31, 2012
Surgical management of malignant bowel obstruction: at what price palliation?Zachary P Englert, Michael A White, Timothy L Fitzgerald, et al.American Heart Journal|September 20, 2005
Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failureRobert L Fitzgerald, Rosemary Cremo, Nancy Gardetto, et al.The Journal of Biological Chemistry|February 1, 2000
Syndecan-1 shedding is enhanced by LasA, a secreted virulence factor of Pseudomonas aeruginosaP W Park, G B Pier, M J Preston, et al.Journal of the American College of Surgeons|February 27, 2018
Frailty Predicts Failure to Rescue after Thoracoabdominal OperationCatalina Mosquera, Juan M Bermudez, Jessica L Evans, et al.Nature Medicine|June 12, 1998
Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2M Kato, H Wang, V Kainulainen, et al.British Journal of Clinical Pharmacology|January 1, 1991
The pharmacokinetics of ifosfamide given as short and long intravenous infusions in cancer patientsL D Lewis, D L Fitzgerald, P Mohan, et al.Pageof 54